Widely used drugs on US imports list from Europe
Item 1 of 2 A combination image shows an injection pen of Zepbound, Eli Lilly's weight loss drug, in New York City, U.S., December 11, 2023 (left) and a box of Mounjaro, a tirzepatide injection drug used for treating type 2 diabetes and made by Lilly, at Rock Canyon Pharmacy in Provo, Utah, U.S., March 29, 2023. REUTERS/Brendan McDermid/George Frey/File Photo
[1/2] A combination image shows an injection pen of Zepbound, Eli Lilly's weight loss drug, in New York City, U.S., December 11, 2023 (left) and a box of Mounjaro, a tirzepatide injection drug used for treating type 2 diabetes and made by Lilly, at Rock Canyon Pharmacy in Provo, Utah, U.S., March 29,... Purchase Licensing Rights, opens new tab Read more
March 18 (Reuters) - Widely used prescription medicines could get caught up in the Trump administration's tariff trade wars and EU retaliation.
The following is a list of major prescription drugs whose ingredients or components are imported into the United States from the European Union, based on U.S. Food and Drug Administration import data from 2023 and 2024.
Keep up with the latest medical breakthroughs and healthcare trends with the Reuters Health Rounds newsletter. Sign up here.
Company Brand Name (chemical name) Used to Treat Country of Import Company Comments
AbbVie (ABBV.N) Rinvoq (upadacitinib) rheumatoid arthritis Germany, Ireland Abbvie declined to comment on specific production or import sites for its drugs. The company said it "maintains a robust, diversified and redundant manufacturing network with geographic balance and multiple supply sites"
Norvir (ritonavir) HIV Germany
Humira (adalimumab) rheumatoid arthritis, psoriatic arthiritis, others Germany
Amgen (AMGN.O) Blincyto (blinatumomab) A type of acute lymphoblastic leukemia Netherlands
Prolia/Xgeva (denosumab) osteoporosis, preventing fractures from cancer in bones Netherlands
Bavarian Nordic A/S (BAVA.CO) Jynneos smallpox vaccine, also used for mpox Denmark Bavarian Nordic said it manufactures all its bulk vaccine/bulk drug substance for Jynneos in Denmark, and the fill and finish is done either at its own site in Denmark or in the U.S., depending on the markets served.
Bristol Myers Squibb (BMY.N) Eliquis (apixaban) Blood thinner/clot preventer Ireland
Opdivo (nivolumab) cancer immunotherapy Ireland
Eli Lilly (LLY.N) Mounjaro, Zepbound (tirzepatide) type 2 diabetes, obesity Germany, Netherlands A Lilly spokesperson said the company prefers to source materials internally, as evidenced by its most recent manufacturing announcements. It does not disclose details of in-house vs external manufacturing
Johnson & Johnson (JNJ.N) Stelara (ustekinumab) inflammatory bowel disease, psoriatic arthritis, other autoimmune conditions Ireland, Netherlands
Invega/Invega Sustenna (paliperidone) schizophrenia Ireland
Merck & Co (MRK.N) ritonavir antiviral Netherlands
Keytruda (pembrolizumab) cancer immunotherapy Netherlands, Ireland
Gardasil HPV vaccine for cancer prevention Ireland
Novavax (NVAX.O) Nuvaxovid COVID-19 vaccine Germany Novavax said its vaccine is manufactured by The Serum Institute in India.
Novo Nordisk (NOVOb.CO) Ozempic (semaglutide ) type 2 diabetes, Ireland, Germany, Denmark Novo said in a statement that it manufactures the active ingredients for its obesity and diabetes drugs in Denmark and United States only
Wegovy (semaglutide) obesity Ireland, Germany
Pfizer (PFE.N) Prevnar family pneumococcal vaccines for pneumonia prevention Ireland
Penbraya meningococcal meningitis vaccine Ireland
Comirnaty COVID-19 vaccine Ireland, Germany
Eliquis (apixaban) blood thinner/clot preventer Netherlands
Regeneron (REGN.O) Eylea (aflibercept ) Wet age-related macular degeneration, other eye conditions Ireland Regeneron has manufacturing facilities in both the U.S. and Ireland and is currently expanding its campus in New York.
Roche (ROG.S) Avastin (bevacizumab) metastatic colorectal cancer, diabetic eye disease and other eye disorders Germany Roche declined to comment on which drug is produced where, and for which market. It said that a majority of its products cross different countries/continents across the development and supply chain.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Scottish Sun
13 minutes ago
- Scottish Sun
Number of fat jab NHS prescriptions doubles in a year as 73% of Sun readers now think about using injections
Prescriptions for Mounjaro surged to 1.1million from just 3,300 a year earlier FAT JAB BRITAIN Number of fat jab NHS prescriptions doubles in a year as 73% of Sun readers now think about using injections Click to share on X/Twitter (Opens in new window) Click to share on Facebook (Opens in new window) ENGLAND has become a fat jab nation as weight loss drug prescriptions double to almost three million in a year. Demand for drugs such as Ozempic and Mounjaro show no signs of slowing, with the NHS splashing out £269million on them in 2024-25. Sign up for Scottish Sun newsletter Sign up 5 Weight loss drug prescriptions in England have doubled to almost three million in a year Credit: Getty 5 Prescriptions for Mounjaro surged to 1.1million from just 3,300 a year earlier Credit: Alamy It comes as a new Sun survey reveals 73 per cent of our readers are thinking of using them as they struggle to shift weight. Official figures show prescriptions for the big three — Ozempic, Mounjaro and Wegovy — rocketed from 1.4million in 2023-24 to 2.7million last year. The increase was driven by Mounjaro, regarded as the strongest jab, with prescriptions surging to 1.1million from just 3,300 a year earlier. Most were prescribed to people with type 2 diabetes, as the injections were designed to treat that condition, and have only recently been approved for weight loss alone. NHS figures suggest prescriptions in Wales also doubled last year, from approximately 34,000 to 70,000, and in Scotland from 40,000 to 50,000. The numbers are expected to rise again this year as the NHS introduces them through slimming clinics. More than a million people are also already buying the jabs privately. Dr Leyla Hannbeck, of the Independent Pharmacies Association, said: 'Never in my career have I seen a product with as much hype as these injections. 'The demand is absolutely huge and I expect it to keep increasing — the only way is up.' Clare Butler, 48, said the jabs also helped her mental health. Weight Loss Jabs - Pros vs Cons The mum, from Manchester, who has lost 4st 4lb, said: 'Mounjaro didn't only quieten the food noise, but it helped quieten the over-thinking, anxious thoughts that had consumed my life for so long.' She described it as, 'the best decision I've ever made for myself'. Research is revealing wide-ranging health benefits to the jabs, such as lowering risks of cancer, heart disease and dementia, yet warnings over weight loss drugs are also increasing. 5 Medics warn they must not be used in pregnancy, while trying to conceive or while breastfeeding, for fear they could lead to miscarriage or birth defects. They have also warned that rapid weight loss caused by the drugs could lead to bone loss and osteoporosis. Annual statistics from the NHS Business Services Authority show the total number of GLP-1 injections prescribed increased from 1,427,968 in the 2023-24 financial year to 2,734,499 in 2024-25. It was a 91 per cent spike — accounted for almost entirely by Mounjaro's growth. 5 Clare Butler lost 4st4lb on Mounjaro Credit: Clare Butler 5 Clare said the jabs not only helped her lose weight but improved her mental health Credit: Clare Butler The totals also included brands such as Saxenda, Ozempic and Wegovy. In the same period, the cost of prescribing rose from £137,808,297 to £269,276,366 — equal to 2.4 per cent of all NHS spending on pharmacy medicines, or £1 in every £42. The NHS said: 'We expect demand for weight loss drugs to continue to rise in the coming years.' The Department of Health added: 'We recognise the drugs' importance for treating type 2 diabetes and their exciting remit as new treatments for obesity.' Unlock even more award-winning articles as The Sun launches brand new membership programme - Sun Club.
The Sun
13 minutes ago
- The Sun
Number of fat jab NHS prescriptions doubles in a year as 73% of Sun readers now think about using injections
ENGLAND has become a fat jab nation as weight loss drug prescriptions double to almost three million in a year. Demand for drugs such as Ozempic and Mounjaro show no signs of slowing, with the NHS splashing out £269million on them in 2024-25. 5 It comes as a new Sun survey reveals 73 per cent of our readers are thinking of using them as they struggle to shift weight. Official figures show prescriptions for the big three — Ozempic, Mounjaro and Wegovy — rocketed from 1.4million in 2023-24 to 2.7million last year. The increase was driven by Mounjaro, regarded as the strongest jab, with prescriptions surging to 1.1million from just 3,300 a year earlier. Most were prescribed to people with type 2 diabetes, as the injections were designed to treat that condition, and have only recently been approved for weight loss alone. NHS figures suggest prescriptions in Wales also doubled last year, from approximately 34,000 to 70,000, and in Scotland from 40,000 to 50,000. The numbers are expected to rise again this year as the NHS introduces them through slimming clinics. More than a million people are also already buying the jabs privately. Dr Leyla Hannbeck, of the Independent Pharmacies Association, said: 'Never in my career have I seen a product with as much hype as these injections. 'The demand is absolutely huge and I expect it to keep increasing — the only way is up.' Clare Butler, 48, said the jabs also helped her mental health. Weight Loss Jabs - Pros vs Cons The mum, from Manchester, who has lost 4st 4lb, said: 'Mounjaro didn't only quieten the food noise, but it helped quieten the over-thinking, anxious thoughts that had consumed my life for so long.' She described it as, 'the best decision I've ever made for myself'. Research is revealing wide-ranging health benefits to the jabs, such as lowering risks of cancer, heart disease and dementia, yet warnings over weight loss drugs are also increasing. 5 Medics warn they must not be used in pregnancy, while trying to conceive or while breastfeeding, for fear they could lead to miscarriage or birth defects. They have also warned that rapid weight loss caused by the drugs could lead to bone loss and osteoporosis. Annual statistics from the NHS Business Services Authority show the total number of GLP-1 injections prescribed increased from 1,427,968 in the 2023-24 financial year to 2,734,499 in 2024-25. It was a 91 per cent spike — accounted for almost entirely by Mounjaro's growth. 5 5 The totals also included brands such as Saxenda, Ozempic and Wegovy. In the same period, the cost of prescribing rose from £137,808,297 to £269,276,366 — equal to 2.4 per cent of all NHS spending on pharmacy medicines, or £1 in every £42. The NHS said: 'We expect demand for weight loss drugs to continue to rise in the coming years.' The Department of Health added: 'We recognise the drugs' importance for treating type 2 diabetes and their exciting remit as new treatments for obesity.'
Scottish Sun
14 minutes ago
- Scottish Sun
Gemma Collins goes on fat jab rant as she slams skinny people who take weight loss injections
GEMMA Collins has slammed skinny people who use fat jabs as opposed to those who actually medically qualifiy. The reality TV star is currently undergoing her own weight loss journey and is currently using Mounjaro in a bid to shift the weight once and for all. 4 Gemma Collins has slammed skinny people who use weight loss jabs Credit: Getty 4 The star is currently on her own weight loss journey Credit: Instagram But although she is using the jabs, she has scolded others who use them when they don't actually 'need' the medication. Speaking to the Mirror, Gemma said: "I really don't agree with already slim people taking it, that's just not right at all, and it's not what it's for. "It's for overweight people and it breaks my heart when there's people on the NHS who can't access it and it's such a shame because everyone deserves not to struggle with their weight and you would only understand if you had a weight problem and how difficult it is. I know how it is." So far, the star revealed she has already dropped from a size 26 to a size 20 and is still continuing on her journey. The star revealed it had given her a much-needed confidence boost and praised the wonder drug. The Diva Forever star said: "I've gone from a size 26 to a size 20, and I've never felt better. "Mounjaro is unbelievable and it's changed my whole life. I think it's a life-changing drug. "Being able to pick up a size 20 top in M&S, put it on in the changing rooms and just get on with my day, is just such a life-changing experience for me honestly." She continued: "Don't be scared or anxious - do it! "You can't just buy them backstreet - there's so many people selling them dangerously and on the backstreet market. Gemma Collins breaks silence on scary pneumonia battle as she struggles to breathe in chaotic radio appearance "You have to go with a proper company and it will seriously change your life. It has been the biggest success for me. I have so much energy. "I just feel good and I'm not obsessed with looking too thin. "I don't need to prove anything to anyone, I know myself that I'm losing the weight and I feel so much healthier. "They really are a wonder-drug and if anyone is struggling with their weight, I really do understand. "I know how difficult it is." Everything to know about Gemma Collins All the latest news about Gemma Collins Who is Gemma's fiance Rami Hawash? Gemma Collins' net worth explained All about Gemma Collins' weight loss Meet Gemma's parents Joan and Alan 4 The star has been aiming to slim down Credit: Alamy
